Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005594-51Phase 4Completed
Phase 4, open-label trial of abiraterone (2 arms), sponsored by KU Leuven. Primary endpoints: Gastrointestinal behavior of abiraterone acetate and Absorption of abiraterone acetate (fasted vs fed). Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005594-51.